• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

    2/8/23 10:50:43 AM ET
    $KIDS
    Medical/Dental Instruments
    Health Care
    Get the next $KIDS alert in real time by email
    SC 13G/A 1 g13kidsamend2.txt ORTHOPEDIATRICS CORP Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) OrthoPediatrics Corp (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68752L100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Rule 13d-1(b) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 68752L100 13G 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Riverbridge Partners LLC 41-1930193 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP N/A (a)____ (b)____ 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Minneapolis, Minnesota NUMBER OF 5. SOLE VOTING POWER SHARES 669,111 BENEFICIALLY 6. SHARED VOTING POWER OWNED BY N/A EACH 7. SOLE DISPOSITIVE POWER REPORTING 941,004 PERSON 8. SHARED DISPOSITIVE POWER WITH N/A 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 941,004 10. CHECK BOX IF AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES N/A 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.63% 12. TYPE OF REPORTING PERSON IA Item 1(a) Name of issuer: OrthoPediatrics Corp Item 1(b) Address of issuer's principal executive offices: 2850 Frontier Drive, Warsaw, IN 46582 Item 2(a) Name of persons filing: Riverbridge Partners LLC Item 2(b) Address or principal business office or, if none, residence: 80 South Eighth St., Suite 1200, Minneapolis, MN 55402 Item 2(c) Citizenship: Minnesota Corporation Item 2(d) Title of class of securities: Common Stock Item 2(e) CUSIP No.: 68752L100 Item 3 If this statement is filed pursuant to rules 13d-1(b), or 13d- 2(b) or (c), check whether the person filing is an: Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940. Item 4 Ownership (a) Amount beneficially owned: 941,004 shares of common stock (b) Percent of class: 4.63% of total shares of common stock outstanding (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 669,111 (ii) Shared power to vote or to direct the vote N/A (iii)Sole power to dispose or to direct the disposition 941,004 (iv) Shared power to dispose or to direct the disposition N/A Item 5 Ownership of Five Percent or Less of a Class. N/A Item 6 Ownership of More than Five Percent on Behalf of Another Person. N/A Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. N/A Item 8 Identification and Classification of Members of the Group. N/A Item 9 Notice of Dissolution of Group. N/A Item 10 Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 7, 2023 Ross M. Johnson Ross M. Johnson/Chief Investment Officer
    Get the next $KIDS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KIDS

    DatePrice TargetRatingAnalyst
    4/7/2025$37.00Buy
    Lake Street
    1/25/2024$39.00 → $31.00Buy → Hold
    Truist
    3/3/2022$83.00 → $65.00Buy
    Needham
    12/22/2021$75.00 → $68.00Buy
    BTIG
    12/21/2021$78.00 → $75.00Buy
    Truist Securities
    8/6/2021$70.00 → $77.00Market Outperform
    JMP Securities
    More analyst ratings

    $KIDS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • General Counsel and Secretary Gerritzen Daniel J was granted 38,773 shares and sold $132,007 worth of shares (5,310 units at $24.86), increasing direct ownership by 43% to 110,767 units (SEC Form 4)

      4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

      3/18/25 2:51:42 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • President and CEO Bailey David R was granted 97,496 shares and sold $164,573 worth of shares (6,620 units at $24.86), increasing direct ownership by 40% to 319,155 units (SEC Form 4)

      4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

      3/18/25 2:50:36 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • COO and CFO Hite Fred sold $160,173 worth of shares (6,443 units at $24.86) and was granted 63,342 shares, increasing direct ownership by 38% to 207,989 units (SEC Form 4)

      4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)

      3/18/25 2:48:44 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care

    $KIDS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by OrthoPediatrics Corp.

      SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

      11/14/24 1:34:08 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

      SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

      5/8/24 2:22:57 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)

      SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)

      2/14/24 3:33:43 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care

    $KIDS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on OrthoPediatrics with a new price target

      Lake Street initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $37.00

      4/7/25 8:25:17 AM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics downgraded by Truist with a new price target

      Truist downgraded OrthoPediatrics from Buy to Hold and set a new price target of $31.00 from $39.00 previously

      1/25/24 7:05:43 AM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • Needham reiterated coverage on OrthoPediatrics with a new price target

      Needham reiterated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $65.00 from $83.00 previously

      3/3/22 11:28:34 AM ET
      $KIDS
      Medical/Dental Instruments
      Health Care

    $KIDS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

      WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of $52.4 million for the first quarter of 2025, up 17% from $44.7 million in first quarter 2024; domestic revenue increased 19% and international revenue increased 11% in the quarterGrew worldwide Trauma & Deformity revenue 14% and worldwide Scoliosis revenue 34% in the first

      5/7/25 4:05:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System

      WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company's 5th FDA approval in 2025. 3P Pediatric Plating Platform Hip System is a new plate and screw platform to modernize and revolutionize trauma and deformity correction treatment in the lower extremities. This family of plating systems will provide surgeons unparalleled coverage for a variety of Trauma and

      5/7/25 4:01:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

      WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for repl

      4/23/25 4:05:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care

    $KIDS
    SEC Filings

    See more
    • SEC Form 10-Q filed by OrthoPediatrics Corp.

      10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)

      5/8/25 3:37:15 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)

      5/7/25 4:14:08 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)

      5/7/25 4:07:47 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care

    $KIDS
    Financials

    Live finance-specific insights

    See more
    • OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance

      WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of $52.4 million for the first quarter of 2025, up 17% from $44.7 million in first quarter 2024; domestic revenue increased 19% and international revenue increased 11% in the quarterGrew worldwide Trauma & Deformity revenue 14% and worldwide Scoliosis revenue 34% in the first

      5/7/25 4:05:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

      WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for repl

      4/23/25 4:05:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

      Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA WARSAW, Ind., March 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 & Recent Business Highlights Helped a new record of over 34,000 children in the fourth quarter 2024 and approximately 138,000 for full year 2024, bringing the total to over 1.14 million since the i

      3/4/25 4:05:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care

    $KIDS
    Leadership Updates

    Live Leadership Updates

    See more
    • OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

      WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​ The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding member

      3/17/25 4:05:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • OrthoPediatrics Joins Alliance for Pediatric Device Innovation

      WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, has announced a strategic partnership with Children's National Hospital in Washington, DC under the "Alliance for Pediatric Device Innovation" (APDI), to advice the development and commercialization of medical devices designed for children. Along with Children's National, APDI consortium members include Johns Hopkins University, CIMIT at Mass General Brigham, Tufts Medical Center and Medstar Health Research Institute. The Company will serve as APDI's strategic advisor and role model for devic

      10/12/23 8:05:00 AM ET
      $KIDS
      Medical/Dental Instruments
      Health Care
    • FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO

      New CEO Paul Mraz also joins FzioMed Inc.'s Board of Directors;  Company set to accelerate growth of market leading Oxiplex® adhesion barrier products. SAN LUIS OBISPO, Calif., Jan. 3, 2023 /PRNewswire/ -- FzioMed, Inc. ("FzioMed" or the "Company"), a global leading surgical biomaterials company focused on spine/orthopedic, peritoneal and gynecological surgery, today announced the appointment of industry veteran Paul Mraz as its new President and CEO and member of the Board of Directors. Mraz's appointment became effective Jan. 1, 2023, commensurate with the retirement of John Krelle who served in the leadership role since 2005. "On behalf of the Board of Directors, I want to thank John for

      1/3/23 12:20:00 PM ET
      $KIDS
      Medical/Dental Instruments
      Health Care